Clinical Trial Location: United States
Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) (CEDAR)
Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%
Aviclear for Hidradenitis Suppurativa (HS)
Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/study/NCT06411379
Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
https://clinicaltrials.gov/study/NCT04414514
Anifrolumab Clinical Trial
https://clinicaltrials.gov/study/NCT06374212
A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients with Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/study/NCT06603077
HS Mindfulness Training Trial
https://clinicaltrials.gov/study/NCT05642039